BR112013029149A2 - processo de produção de material inorgânico em partículas - Google Patents

processo de produção de material inorgânico em partículas

Info

Publication number
BR112013029149A2
BR112013029149A2 BR112013029149A BR112013029149A BR112013029149A2 BR 112013029149 A2 BR112013029149 A2 BR 112013029149A2 BR 112013029149 A BR112013029149 A BR 112013029149A BR 112013029149 A BR112013029149 A BR 112013029149A BR 112013029149 A2 BR112013029149 A2 BR 112013029149A2
Authority
BR
Brazil
Prior art keywords
particulate material
inorganic particulate
production process
material production
inorganic
Prior art date
Application number
BR112013029149A
Other languages
English (en)
Inventor
Peters Benjamin
Saal Christoph
Breiningen Eugenia
Cabrera Perez Karin
Maio Mario
Schulz Michael
Puchert Thomas
Lang Ulrich
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR112013029149A2 publication Critical patent/BR112013029149A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C01B33/141—Preparation of hydrosols or aqueous dispersions
    • C01B33/142—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates
    • C01B33/143—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates of aqueous solutions of silicates
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • C01B33/187—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates
    • C01B33/193—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates of aqueous solutions of silicates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Silicon Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo patente de invenção: "processo de produção de material inorgânico em partículas". a presente invenção é dirigida a um processo para a produção de material inorgânico em partículas, ao material obtido por meio deste processo, a um sistema de distribuição com liberação modificada, compreendendo o material e ao uso do material para a administração de um agente bioativo.
BR112013029149A 2011-05-13 2012-04-25 processo de produção de material inorgânico em partículas BR112013029149A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11003961 2011-05-13
PCT/EP2012/001769 WO2012156023A1 (en) 2011-05-13 2012-04-25 Process for producing inorganic particulate material

Publications (1)

Publication Number Publication Date
BR112013029149A2 true BR112013029149A2 (pt) 2017-02-07

Family

ID=46022158

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013029149A BR112013029149A2 (pt) 2011-05-13 2012-04-25 processo de produção de material inorgânico em partículas

Country Status (18)

Country Link
US (1) US9517268B2 (pt)
EP (1) EP2707329B1 (pt)
JP (1) JP6040497B2 (pt)
KR (1) KR101906792B1 (pt)
CN (1) CN103534208B (pt)
AR (1) AR086346A1 (pt)
AU (1) AU2012258092B2 (pt)
BR (1) BR112013029149A2 (pt)
CA (1) CA2836782A1 (pt)
DK (1) DK2707329T3 (pt)
EA (1) EA201301264A1 (pt)
ES (1) ES2657822T3 (pt)
IL (1) IL229209A (pt)
MX (1) MX352176B (pt)
PT (1) PT2707329T (pt)
SG (1) SG194820A1 (pt)
WO (1) WO2012156023A1 (pt)
ZA (1) ZA201309469B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10577250B2 (en) 2011-05-13 2020-03-03 Merck Patent Gmbh Process for producing of inorganic particulate material
WO2014072015A1 (en) * 2012-11-12 2014-05-15 Merck Patent Gmbh Use of silicon oxide-based material for the modified release of biologically active agents
AU2014356854B2 (en) * 2013-11-26 2017-11-16 Merck Patent Gmbh Process for producing inorganic particulate material
EP3636282A4 (en) 2017-05-19 2020-11-04 Tokuyama Corporation CARRIERS OF A PHARMACEUTICAL INGREDIENT AND METHOD OF MANUFACTURING THEREOF
CN110133765A (zh) * 2018-02-08 2019-08-16 法国圣戈班玻璃厂 带有耐污层的光学组件及其制备方法和应用
JP7352936B2 (ja) * 2018-08-17 2023-09-29 地方独立行政法人東京都立産業技術研究センター 多孔質シリカ、機能材料および多孔質シリカの製造方法
WO2020127281A1 (en) 2018-12-20 2020-06-25 Merck Patent Gmbh A release system comprising a bioactive agent and a particulate material
WO2021220507A1 (ja) * 2020-05-01 2021-11-04 昭和電工マテリアルズ株式会社 多孔質体形成用塗液、多孔質体及び多孔質体の製造方法
JP6924338B1 (ja) * 2021-01-29 2021-08-25 三井金属鉱業株式会社 ゾル、ゲル及びシリカ多孔体を製造する装置及び方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070216A (en) * 1964-03-09 1967-06-01 Grace W R & Co Improvements in or relating to silica and silica-alumina gels
JP3985171B2 (ja) 1996-12-26 2007-10-03 直弘 曽我 無機系多孔質体の製造方法
JP3985170B2 (ja) 1996-12-26 2007-10-03 直弘 曽我 無機系多孔質体の製造方法
EP1298097A1 (en) * 1996-12-26 2003-04-02 MERCK PATENT GmbH Method for producing porous inorganic materials
EP0963342B1 (en) * 1997-02-24 2003-04-09 Dow Corning Corporation Neutral-aged hydrophobic silica gels with reduced surface area
JPH11292528A (ja) * 1998-01-23 1999-10-26 Naohiro Soga 無機多孔質材料の製造法
DE69841079D1 (de) 1998-01-23 2009-10-01 Merck Patent Gmbh Verfahren zur herstellung von inorganischem material in einer kapillare
EP1202745A4 (en) * 1999-08-16 2004-09-22 Henceforth Hibernia Inc THERAPEUTIC AND PROPHYLACTIC COMPOSITIONS CONTAINING CATALYTIC BIOMIMETIC SOLIDS AND METHODS OF PREPARING AND USING SAME
PT1419106T (pt) 2001-08-13 2016-12-27 Rhodia Chimie Sa Processo de preparação de sílicas, sílicas com distribuição granulométrica e/ou repartição porosa específicas e suas utilizações, em particular no reforço de polímeros
DK1599186T3 (da) 2003-02-24 2013-07-08 Pharmaceutical Productions Inc System til administration af transmukalt lægemiddel
GB0315012D0 (en) 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
JP4519433B2 (ja) * 2003-09-17 2010-08-04 株式会社トクヤマ 微粒子状メソポーラスシリカ
EP1702886A4 (en) 2003-09-11 2011-02-16 Taiyo Kagaku Kk POROUS SILICA WHICH CARRYS A SUBSTANCE
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
US20070224133A1 (en) 2006-03-23 2007-09-27 Mcgill Patrick D High-cleaning silica materials made via product morphology control under high shear conditions
JP2009013142A (ja) * 2007-07-09 2009-01-22 Kyoto Univ 徐放用メソポーラスシリカ
CN101348713A (zh) * 2007-07-20 2009-01-21 同济大学 能发射荧光的磁性复合纳米微球及其制备方法
CN101113247A (zh) 2007-09-05 2008-01-30 广州市飞雪化工有限公司 一种透明磨擦粒子的制备方法
CN101250313B (zh) * 2008-03-19 2010-12-08 中国科学院化学研究所 纳米粒子复合物及其制备方法
CN101343065A (zh) * 2008-09-04 2009-01-14 复旦大学 一种纳米二氧化硅空心球材料及其制备方法
CN101412517A (zh) 2008-11-14 2009-04-22 华东理工大学 孔径可控的介孔二氧化硅微球的制备方法及应用
JP5426869B2 (ja) * 2008-11-19 2014-02-26 パナソニック株式会社 メソポーラスシリカ微粒子の製造方法、メソポーラスシリカ微粒子含有組成物、及びメソポーラスシリカ微粒子含有成型物
JP4521477B1 (ja) * 2009-01-15 2010-08-11 水澤化学工業株式会社 非晶質シリカ
CN101559952A (zh) * 2009-05-13 2009-10-21 南京工业大学 一种纳米尺度介孔二氧化硅球的制备方法
CN101829331A (zh) 2010-05-28 2010-09-15 沈阳药科大学 一种适用于难溶性药物的三维有序大孔二氧化硅给药体系

Also Published As

Publication number Publication date
KR101906792B1 (ko) 2018-10-11
WO2012156023A1 (en) 2012-11-22
ES2657822T3 (es) 2018-03-07
AU2012258092A1 (en) 2014-01-09
DK2707329T3 (en) 2018-01-15
EP2707329B1 (en) 2017-11-01
EP2707329A1 (en) 2014-03-19
JP2014522363A (ja) 2014-09-04
EA201301264A1 (ru) 2014-04-30
US9517268B2 (en) 2016-12-13
AU2012258092B2 (en) 2015-08-20
PT2707329T (pt) 2018-02-07
ZA201309469B (en) 2014-08-27
US20140336274A1 (en) 2014-11-13
AR086346A1 (es) 2013-12-04
MX2013013135A (es) 2014-02-11
CN103534208A (zh) 2014-01-22
KR20140033122A (ko) 2014-03-17
IL229209A (en) 2016-12-29
MX352176B (es) 2017-11-13
CA2836782A1 (en) 2012-11-22
WO2012156023A8 (en) 2014-01-30
SG194820A1 (en) 2013-12-30
JP6040497B2 (ja) 2016-12-07
IL229209A0 (en) 2014-01-30
CN103534208B (zh) 2017-07-18

Similar Documents

Publication Publication Date Title
BR112013029149A2 (pt) processo de produção de material inorgânico em partículas
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
CL2013003372A1 (es) Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
BR112014010900A2 (pt) métodos de preparar sistema de catalisador
BR112015028564A2 (pt) encapsulados
BR112014020826A2 (pt) moduladores e métodos de uso
BR112012009206A2 (pt) agente de beta-nucleação em nanoescala para polipropileno
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
BR112014011162A2 (pt) derivados purínicos para o tratamento de infecções virais
BR112014022214A2 (pt) fenólicos antibacterianos
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
CO7131375A2 (es) Uracilos sustituidos bicíclicamente y uso de los mismos
BR112013028449A2 (pt) composições compreendendo partículas de hidrogel
BRPI1006902A2 (pt) formulação farmacêutica ou alimentícia de liberação controlada, processo para a produção de uma forma farmacêutica ou alimentícia, sistema de liberação controlada, e, uso de um sistema de liberação controlada
BR112014009866A2 (pt) formulações de anticorpos e métodos
PE20140255A1 (es) Tableta dispersable en forma oral
BR112014011381A2 (pt) artigos absorventes com sistemas de fixação por gancho e laço
BR112015018071A2 (pt) estra-1,3,5(10),16-tetraeno-3-carboxamidas
CL2013001770A1 (es) Proceso para la fabricacion de productos autoclavado de fibrocemento; y producto autoclavado de fibrocemento.
BR112015000443A2 (pt) derivados de estra-1,3,5(10),16-tetraeno 3-substituídos, processo para a sua produção, preparações farmacêuticas que contêm os mesmos, bem como seu uso para a produção de medicamentos
BR112014010374A2 (pt) alimento para animais, uso de uma xilanase hiper-termofílica e hiper-termoestável, uso do alimento para animais e processo para produzir alimento para animais
BR112014002674A2 (pt) 3-(bifenil-3-il)-4-hidróxi-8-metóxi-1-azaspiro[4.5]dec-3-en-2-onas substituídas
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
BR112014027092A2 (pt) partículas e métodos para a produção de partículas
BR112014010509A2 (pt) sistema de dispensa vaginal osmoticamente ativo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL